ADMA Biologics Inc (ADMA): Price and Financial Metrics

ADMA POWR Grades

• ADMA scores best on the Growth dimension, with a Growth rank ahead of 79.22% of US stocks.
• ADMA's strongest trending metric is Growth; it's been moving up over the last 52 weeks.
• ADMA ranks lowest in Quality; there it ranks in the 0th percentile.

ADMA Stock Summary

• As for revenue growth, note that ADMA's revenue has grown 56.02% over the past 12 months; that beats the revenue growth of 87.99% of US companies in our set.
• In terms of volatility of its share price, ADMA is more volatile than 86.11% of stocks we're observing.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ADMA comes in at -69.63% -- higher than that of only 3.89% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Adma Biologics Inc are NGVT, LNDC, LXFR, ASUR, and CLS.
• ADMA's SEC filings can be seen here. And to visit Adma Biologics Inc's official web site, go to www.admabiologics.com.

ADMA Valuation Summary

• ADMA's price/sales ratio is 3.1; this is 18.42% lower than that of the median Healthcare stock.
• ADMA's EV/EBIT ratio has moved up 2.2 over the prior 96 months.
• Over the past 96 months, ADMA's price/sales ratio has gone down 41.8.

Below are key valuation metrics over time for ADMA.

ADMA Growth Metrics

• Its year over year price growth rate is now at -47.81%.
• The 4 year price growth rate now stands at -46.04%.
• The 4 year net income to common stockholders growth rate now stands at -186.96%.

Over the past 67 months, ADMA's revenue has gone up $50,934,020.

The table below shows ADMA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	58.11165	-121.5629	-73.61047
2021-03-31	48.06866	-110.5851	-74.88326
2020-12-31	42.21978	-102.003	-75.74855
2020-09-30	40.30074	-89.43556	-66.9018
2020-06-30	37.24689	-89.2138	-61.42281
2020-03-31	36.02024	-86.55328	-54.45659

ADMA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ADMA has a Quality Grade of F, ranking ahead of 0.13% of graded US stocks.
• ADMA's asset turnover comes in at 0.268 -- ranking 168th of 680 Pharmaceutical Products stocks.
• NOVN, ZYNE, and VBIV are the stocks whose asset turnover ratios are most correlated with ADMA.

The table below shows ADMA's key quality metrics over time.